
Today’s Yangtze funding roundup: Biopharma, physical AI infra…
Biotech and physical AI startups raised fresh capital to advance clinical programs and next-generation robotics infrastructure.

Biotech and physical AI startups raised fresh capital to advance clinical programs and next-generation robotics infrastructure.

The “Solar Valley” will comprise three zones covering scientific research, industrial support and startup incubation.

The company delivered about 30,000 units globally in 2025, with products sold across more than 70 countries and regions.

The company aims to move 3D content creation from labor-intensive manual modeling toward automated, large-scale production.

As companies move toward commercialization, major competitions can serve as public demonstrations of technical capability.

That makes the program resemble an early-stage technology grant or angel investment more than a conventional corporate recruitment scheme.